ライフサイエンスコーパス: urinary incontinence

1 ructive pulmonary disease (COPD), asthma, or urinary incontinence.

2 durethral-sling surgery in women with stress urinary incontinence.

3 se of medication or indwelling catheters for urinary incontinence.

4 en inducing nerve damage to create models of urinary incontinence.

5 organ prolapse are at risk for postoperative urinary incontinence.

6 l cord neurons, astroglial cells and myelin; urinary incontinence.

7 n the frequency of daily episodes of urgency urinary incontinence.

8 omboembolic events, gallbladder disease, and urinary incontinence.

9 benefits of preventing postoperative stress urinary incontinence.

10 of complications of sling surgery for stress urinary incontinence.

11 tectomy would result in 1 additional case of urinary incontinence.

12 for the treatment of mild-to-moderate stress urinary incontinence.

13 which NA reuptake inhibitors improve stress urinary incontinence.

14 instay for treating postprostatectomy stress urinary incontinence.

15 ls per week, multiple chronic illnesses, and urinary incontinence.

16 ve intervention for all patients with stress urinary incontinence.

17 r watery stools, poor self-rated health, and urinary incontinence.

18 of operative procedure for women with stress urinary incontinence.

19 ogen resulted in inconsistent improvement of urinary incontinence.

20 have a high success rate for treating stress urinary incontinence.

21 nue drug therapy and maintain improvement in urinary incontinence.

22 reporting on surgical management for stress urinary incontinence.

23 ice in patients with neurogenic bladders and urinary incontinence.

24 Duloxetine improved but did not resolve urinary incontinence.

25 Adrenergic drugs did not resolve or improve urinary incontinence.

26 Electrical stimulation failed to resolve urinary incontinence.

27 condary stress urinary incontinence and urge urinary incontinence.

28 e front-line therapeutic modality for stress urinary incontinence.

29 sodes per 24 hours), with or without urgency urinary incontinence.

30 n a woman's bladder and vagina, resulting in urinary incontinence.

31 ult women, include pelvic organ prolapse and urinary incontinence.

32 iological slings for the treatment of stress urinary incontinence.

33 atient-adjusted probability of postoperative urinary incontinence.

34 s been used to manage stress, urge and mixed urinary incontinence.

35 be discussed with patients with intractable urinary incontinence.

36 er alternatives in difficult cases of stress urinary incontinence.

37 ing, or other medical conditions can lead to urinary incontinence.

38 ews the data on its use in the management of urinary incontinence.

39 atment of choice in the management of stress urinary incontinence.

40 etry) prior to surgical treatment for stress urinary incontinence.

41 nd therapeutic options for women affected by urinary incontinence.

42 involving 381 women with refractory urgency urinary incontinence.

43 n controlling refractory episodes of urgency urinary incontinence.

44 bit urinary frequency, urgency, and at times urinary incontinence.

45 e evidence regarding the efficacy of PTNS in urinary incontinence.

46 ogynecologic surgery, urinary retention, and urinary incontinence.

47 archical fashion which minimizes the risk of urinary incontinence.

48 in the treatment of the components of mixed urinary incontinence.

49 xperienced significant reductions in urgency urinary incontinence (-0.88 vs -0.31, P=.005), urgency e

50 ation (23.3 [13.7] vs 24.6 [14.0]; P = .36), urinary incontinence (10.6 [17.7] vs 9.7 [15.8]; P = .99

51 olism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI, 880 to 16

52 isease (33 more per 10 000 woman-years), and urinary incontinence (1271 more per 10 000 woman-years).

53 d cortical atrophy (P = .01), nonobstructive urinary incontinence (18.5% vs 3.9%; P = .04), and synco

54 [33%-41%] to 15% [12%-20%], p < 0.001), and urinary incontinence (43% [39%-47%) to 29% [24%-35%], p

55 ), reoperation (4.1% vs. 3.0%, p = 0.758) or urinary incontinence (5.0% vs. 0%, p = 0.195).

56 s 10 to 12 points for sexual function, 6 for urinary incontinence, 5 for urinary irritative symptoms,

57 was 10 to 12 for sexual function, 6 to 9 for urinary incontinence, 5 to 7 for urinary irritative symp

58 ethral strictures (17.8% vs 9.5%), and total urinary incontinence (6.5% vs 2.8%).

59 mentia (22 more per 10 000 woman-years), and urinary incontinence (872 more per 10 000 woman-years).

60 ]), stroke (9 more cases [95% CI, 2 to 19]), urinary incontinence (876 more cases [95% CI, 606 to 116

61 of women (95% CI, 13.2%-18.2%) experiencing urinary incontinence, 9.0% of women (95% CI, 7.3%-10.7%)

62 Mixed urinary incontinence, a condition of both stress and urg

63 , 1.28; 95% CI, 1.08 to 1.52; P = .005), and urinary incontinence (adjusted OR, 1.42; 95% CI, 1.20 to

64 sor overactivity are the major categories of urinary incontinence affecting men.

65 Male urinary incontinence affects a significant number of eld

66 Stress urinary incontinence after prostate cancer treatment is

67 Urinary incontinence after treatment for prostate cancer

68 At 12 months, urinary incontinence (allowing for subsequent treatment

69 associated with better resident outcomes of urinary incontinence among organizational factors.

70 e social consequences of the surgery such as urinary incontinence, anastomotic contracture, erectile

71 Rates of urinary incontinence and anastomotic stricture are accep

72 re rate for patients with predominant stress urinary incontinence and can safely be placed at the tim

73 The management of children with urinary incontinence and dysfunctional voiding problems

74 Urinary incontinence and erectile and sexual dysfunction

75 ic mortality rates, and improved recovery of urinary incontinence and erectile function after open ra

76 most efficacious treatment for severe stress urinary incontinence and for radiated patients.

77 uestionnaires, were participants' reports of urinary incontinence and incremental cost per quality-ad

78 rve stimulation to treat overactive bladder, urinary incontinence and interstitial cystitis (also kno

79 ence-based assessment and management of both urinary incontinence and its associated conditions.

80 e use of conservative management in men with urinary incontinence and other LUTS.

81 g-term complications from mesh use in stress urinary incontinence and pelvic organ prolapse repair ar

82 aised about the safety of surgery for stress urinary incontinence and pelvic organ prolapse using tra

83 advances for the treatment of female stress urinary incontinence and pelvic organ prolapse.

84 to use synthetic grafts in repair of stress urinary incontinence and pelvic organ prolapse.

85 with the use of vaginal mesh for both stress urinary incontinence and POP.

86 Two months after surgery, he had mild stress urinary incontinence and PSA of < 0.1 ng/mL.

87 main types of incontinence in women, stress urinary incontinence and urge urinary incontinence, can

88 l sacrocolpopexy can reduce secondary stress urinary incontinence and urge urinary incontinence.

89 erations have been developed to treat stress urinary incontinence and yet, at present, there is no co

90 as concerned about the potential for greater urinary incontinence and/or urinary irritation associate

91 obstruction and irritation, 9.7 to 10.5 for urinary incontinence, and 5.7 to 6.1 for bowel problems.

92 unction, urinary obstruction and irritation, urinary incontinence, and bowel problems-each scored fro

93 imately three times the rate of diagnosis of urinary incontinence, and more than four times the rate

94 slowing, balance difficulties with falls and urinary incontinence, and one was wheelchair bound.

95 d proportion of fistula recurrence, residual urinary incontinence, and pregnancy after successful fis

96 d basic sociodemographics, cognitive status, urinary incontinence, and self-reported ability to do ac

97 Women were eligible if they had current urinary incontinence, and were excluded if they had a th

98 was due to claims indicative of urethritis, urinary incontinence, and/or obstruction.

99 Group exercise-based programmes for urinary incontinence appear to be promising low-cost int

100 Women with urge urinary incontinence are commonly treated with antimusca

101 and minimally-invasive therapies for stress urinary incontinence are expanding.

102 Importance: Women with refractory urgency urinary incontinence are treated with sacral neuromodula

103 s lesion (NHIC), and 24 patients with stress urinary incontinence as controls were enrolled.

104 ures, which required a negative pad test, no urinary incontinence (as recorded in a 3-day diary), a n

105 In trial 2, the difference in the rate of urinary incontinence at 12 months (126 [65%] of 194) fro

106 e intervention group in trial 1, the rate of urinary incontinence at 12 months (148 [76%] of 196) was

107 to treat with a sling to prevent one case of urinary incontinence at 12 months was 6.3.

108 prolapse surgery resulted in a lower rate of urinary incontinence at 3 and 12 months but higher rates

109 ring prostatectomy was associated with worse urinary incontinence at 5 years (adjusted mean differenc

110 Prevention of postoperative stress urinary incontinence at the time of prolapse repair is c

111 it is less clear that the severity of stress urinary incontinence, based on either abdominal leak poi

112 Thus, it is important that urinary incontinence be amenable to improving conditions

113 Among women with mixed urinary incontinence, behavioral and pelvic floor muscle

114 ntinence in men compared with women, despite urinary incontinence being relatively common and burdens

115 aged >/=65 years), gallbladder disease, and urinary incontinence; benefits included decreased hip fr

116 our domains (urinary irritative-obstructive, urinary incontinence, bowel, and sexual), significant HR

117 ikely to have complete resolution of urgency urinary incontinence but had higher rates of transient u

118 n established and modifiable risk factor for urinary incontinence, but conclusive evidence for a bene

119 onabotulinumtoxinA are used to treat urgency urinary incontinence, but data directly comparing the tw

120 nce exists concerning its efficacy in stress urinary incontinence, but its benefit to women with mixe

121 increased public awareness of the problem of urinary incontinence, but many new products are being in

122 ine exerts only modest relief of male stress urinary incontinence, but may be recommended in some pat

123 performed in women before surgery for stress urinary incontinence, but there is no good evidence that

124 inence with weight loss, for treating stress urinary incontinence by performing anti-incontinence pro

125 at patients with more severe forms of stress urinary incontinence by urodynamic testing fare more poo

126 The term intractable urinary incontinence can be applied to urinary incontine

127 been identified, and studies have shown that urinary incontinence can have substantial negative impac

128 women, stress urinary incontinence and urge urinary incontinence, can be evaluated by history and si

129 re the organizational factors that influence urinary incontinence care quality controlling for patien

130 mine the impact of organizational factors on urinary incontinence care quality defined as the improve

131 emorrhage (p=0.014), dysphagia (p=0.003) and urinary incontinence/catheterisation (p=0.000) were at h

132 ms such as mood changes, sleep disturbances, urinary incontinence, cognitive changes, somatic complai

133 Oxybutynin or tolterodine resolved urinary incontinence compared with placebo (pooled risk

134 al hormone administration increased rates of urinary incontinence compared with placebo in most RCTs

135 r muscle training alone resolved or improved urinary incontinence compared with regular care, althoug

136 the pharmacological treatment of male stress urinary incontinence, confirming that duloxetine had a m

137 al tape is the foremost technique for stress urinary incontinence correction, many of the newer modal

138 Subjective stress urinary incontinence 'cure/improvement' rates after surg

139 Clinicians should prioritize urinary incontinence detection, identify and treat modif

140 The Questionnaire for Urinary Incontinence Diagnosis, the Psychological Genera

141 e from baseline mean number of daily urgency urinary incontinence episodes over 6 months, was measure

142 loss reduced the frequency of self-reported urinary-incontinence episodes among overweight and obese

143 overweight and obese women with at least 10 urinary-incontinence episodes per week to an intensive 6

144 we recorded 24 cases of post-repair residual urinary incontinence, equivalent to a cumulative inciden

145 ics in the preoperative assessment of stress urinary incontinence, especially at this time of rapid c

146 cantly higher prevalence of hearing trouble, urinary incontinence, falls, depression, and osteoporosi

147 Pelvic floor disorders (urinary incontinence, fecal incontinence, and pelvic org

148 systemic or pulmonary arterial hypertension, urinary incontinence, gastrointestinal and neuropsychiat

149 he recommendations made by the Female Stress Urinary Incontinence Guidelines Panel summary report.

150 dies are getting closer to the female stress urinary incontinence guidelines.

151 A man in his 30s with paraparesis and urinary incontinence had a long-segment thoracic lesion

152 The use of slings to treat female stress urinary incontinence has had resurgence with new surgica

153 asive techniques emerge, treatment of stress urinary incontinence has increased over time.

154 re known to be effective in stress and mixed urinary incontinence, has demonstrated that this therapy

155 As treatment strategies for stress urinary incontinence have developed over the last severa

156 new drug treatments and surgical devices for urinary incontinence have had mixed results; direct-to-c

157 < .0001) domains among BT patients, whereas urinary incontinence HRQOL worsened for both the BT (P =

158 s outcomes in the treatment of female stress urinary incontinence illustrate many of the current prob

159 The odds of urinary incontinence improvement from admission in urban

160 n 96%, falls in 76%, pyramidal signs in 54%, urinary incontinence in 50% and dementia in 39%.Visual h

161 ctors associated with prevalent and incident urinary incontinence in a diverse cohort of midlife wome

162 e frequently used in the treatment of stress urinary incontinence in a variety of patients.

163 nsider when choosing an operation for stress urinary incontinence in an individual patient.

164 sed successfully for the treatment of stress urinary incontinence in both male and female patients.

165 dverse events of these procedures for stress urinary incontinence in England over 8 years.

166 ocedure for contemporary treatment of stress urinary incontinence in individual patients.

167 Recent research has focused less on urinary incontinence in men compared with women, despite

168 re are excellent options for managing stress urinary incontinence in men, and recent data have allowe

169 y updated information on the epidemiology of urinary incontinence in men.

170 wo decades, relatively little is known about urinary incontinence in non-White women or in men.

171 studies demonstrate that surgery for stress urinary incontinence in older women improves symptoms, a

172 ise intervention has the potential to manage urinary incontinence in older women in communities large

173 The clinical management of urinary incontinence in people with dementia with medica

174 s may be pragmatically appropriate to manage urinary incontinence in select patients.

175 -years at risk (95% confidence interval) for urinary incontinence in the dementia cohort, among men a

176 lation has been approved for use in treating urinary incontinence in the United States since 1997, an

177 pproach to the surgical management of stress urinary incontinence in women and marked a resurgence in

178 dence base for surgical management of stress urinary incontinence in women between July 2006 and Dece

179 Urinary incontinence in women is a common problem that a

180 rgan prolapse decreases postoperative stress urinary incontinence in women without preoperative sympt

181 uscle training and bladder training resolved urinary incontinence in women.

182 s on the evaluation and management of stress urinary incontinence in women.

183 cal intervention for the treatment of stress urinary incontinence in women.

184 Mixed urinary incontinence, including both stress and urgency

185 ave also examined risk factors and impact of urinary incontinence, including lifestyle, comorbidities

186 For women with stress urinary incontinence, initial midurethral-sling surgery,

187 Urinary incontinence is a common clinical problem, parti

188 Urinary incontinence is a common geriatric syndrome that

189 Urinary incontinence is a socially disabling condition w

190 Conservative treatment for urinary incontinence is an effective intervention and ha

191 Urinary incontinence is an important condition affecting

192 Urinary incontinence is common immediately after prostat

193 Urinary incontinence is common in women, although few se

194 Urinary incontinence is common in women, but is under-re

195 Urinary incontinence is common in women.

196 The treatment of male urinary incontinence is constantly evolving, with recent

197 y evidence for treatment of women with mixed urinary incontinence is lacking, as are clear diagnostic

198 ce for a beneficial effect of weight loss on urinary incontinence is lacking.

199 Male urinary incontinence is often seen following prostate su

200 tinence, a condition of both stress and urge urinary incontinence, is prevalent in 20% to 36% of wome

201 , or both (LR range, 2.2-2.8), and new-onset urinary incontinence (LR, 4.6; 95% CI, 2.8-7.6) increase

202 Patients with stress urinary incontinence mainly suffer from malfunction of t

203 A decrease in urinary incontinence may be another benefit among the ex

204 ry outcomes were success in terms of overall urinary-incontinence measures, which required a negative

205 advocated as first-line treatment for stress urinary incontinence; midurethral-sling surgery is gener

206 fter vaginal surgery for prolapse and stress urinary incontinence, neither ULS nor SSLF was significa

207 n may offer new avenues for the treatment of urinary incontinence of central origin.

208 P = .19).None of the patients presented with urinary incontinence or erectile dysfunction.

209 One primary end point was urinary incontinence or treatment for this condition at

210 At 3 months, the rate of urinary incontinence (or treatment) was 23.6% in the sli

211 tocele (OR, 4.9; 95% CI, 1.3-19), and stress urinary incontinence (OR, 3.1; 95% CI, 1.4-6.5), but not

212 ailure (symptomatic orthostatic hypotension, urinary incontinence, or both) at diagnosis (n=62) had a

213 bstantial number of epidemiologic studies of urinary incontinence over the past two decades, relative

214 Stress urinary incontinence, overflow incontinence and detrusor

215 generation has shown promise in adult stress urinary incontinence patients, but its applicability to

216 nce who had five or more episodes of urgency urinary incontinence per 3-day period, as recorded in a

217 on from baseline in mean episodes of urgency urinary incontinence per day over the 6-month period, as

218 The mean reduction in episodes of urgency urinary incontinence per day over the course of 6 months

219 mplications such as erectile dysfunction and urinary incontinence persist at high incidence rates.

220 Randomized trials in women with mixed urinary incontinence populations are needed.

221 omen with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alo

222 uccess rates' published for different stress urinary incontinence procedures.

223 ssue exposure can lead to urinary frequency, urinary incontinence, proctitis, and erectile dysfunctio

224 nence due to overactive bladder or to stress urinary incontinence published in peer-reviewed journals

225 omes included complete resolution of urgency urinary incontinence, quality of life, use of catheters,

226 Proper diagnosis and evaluation of stress urinary incontinence remains paramount in preventing sur

227 its of the MSC secretome in models of stress urinary incontinence, renal disease, bladder dysfunction

228 s, we give insight into the future of stress urinary incontinence research and outcomes.

229 Urinary incontinence (score of >or=3 on a validated inco

230 anded Prostate Cancer Index Composite (EPIC) urinary incontinence scores were similar at baseline as

231 ders such as overactive bladder syndrome and urinary incontinence significantly increase with age.

232 appropriate interventions, since a change in urinary incontinence status can reflect care quality in

233 eviation (0.19) in the RN ratio, the odds of urinary incontinence status improvement or maintenance o

234 e care quality defined as the improvement of urinary incontinence status or maintenance of continent

235 There are an increasing number of urinary incontinence studies outside Europe and North Am

236 ctive parameters in the evaluation of stress urinary incontinence, such as questionnaires, pad test,

237 logy in a preclinical canine model of stress urinary incontinence (SUI) and no measurable functional

238 ginal meshes used in the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (PO

239 (1) identify risk factors related to stress urinary incontinence (SUI) and postnatal depression (PD)

240 etic slings for the treatment of male stress urinary incontinence (SUI) has increased over the last d

241 Stress urinary incontinence (SUI) is a common and bothersome co

242 elvic organ prolapse (POP) repair and stress urinary incontinence (SUI) to augment and strengthen wea

243 Stress urinary incontinence (SUI) with more than 1 symptom or i

244 ncluding pelvic organ prolapse (POP), stress urinary incontinence (SUI), urge urinary incontinence (U

245 ent evidence for the genetic basis of stress urinary incontinence (SUI).

246 common surgical treatment for female stress urinary incontinence (SUI).

247 ts from randomized trials focusing on stress urinary incontinence surgery in older women are needed.

248 review recently published studies on stress urinary incontinence surgery outcomes in older women.

249 mall statistically significant difference in urinary incontinence symptoms at 12 months that did not

250 r with moderate or severe stress and urgency urinary incontinence symptoms for at least 3 months, and

251 ical prostatectomy was associated with worse urinary incontinence than EBRT (-18.0 points; 95% CI, -2

252 th a greater decrease in sexual function and urinary incontinence than either EBRT or active surveill

253 going prostatectomy were more likely to have urinary incontinence than were those undergoing radiothe

254 table urinary incontinence can be applied to urinary incontinence that cannot be managed using conven

255 n, a significant portion of whom report urge urinary incontinence that is inadequately treated with f

256 serious neurologic disease) associated with urinary incontinence, the clinician should initiate unsu

257 Urinary incontinence, the involuntary loss of urine, is

258 High-quality, level 1 evidence for urinary incontinence therapy can guide clinicians in the

259 s of care have not changed significantly for urinary incontinence, there have been recent advances wi

260 omen with uncomplicated, demonstrable stress urinary incontinence to compare outcomes after preoperat

261 The Urinary Incontinence Treatment Network and Pelvic Floor

262 is lacking regarding the treatment of mixed urinary incontinence, treatment generally begins with co

263 levance: Among women with refractory urgency urinary incontinence, treatment with onabotulinumtoxinA

264 Urinary incontinence treatments yield high levels of pat

265 Urinary incontinence (UI) affects between 40 and 60% of

266 aged 18 or over with a diagnosis of stroke; urinary incontinence (UI) as defined by the Internationa

267 Urinary incontinence (UI) in women adversely affects qua

268 ht loss involving diet modification improves urinary incontinence (UI) in women, but little is known

269 mmendations on the nonsurgical management of urinary incontinence (UI) in women.

270 Urinary incontinence (UI) is common among women and cont

271 Urinary incontinence (UI), a common malady in women, mos

272 Although pregnancy is a risk factor for urinary incontinence (UI), the extent of UI in nulligrav

273 ith severe dysfunctional urination including urinary incontinence (UI).

274 Women without stress urinary incontinence undergoing vaginal surgery for pelv

275 ated measures to assess functional outcomes (urinary incontinence, urinary irritation and obstruction

276 OP), stress urinary incontinence (SUI), urge urinary incontinence (UUI), and hernias, are not well un

277 Common issues for these patients include urinary incontinence, vaginal stenosis, clitoral pain, a

278 rate ratio for pharmacological treatment of urinary incontinence was 2.2 (1.4-3.7) for both genders,

279 e adjusted rate ratio for first diagnosis of urinary incontinence was 3.2 (2.7-3.7) in men and 2.7 (2

280 th active surveillance at 3 months, worsened urinary incontinence was associated with radical prostat

281 reat both apical vaginal prolapse and stress urinary incontinence was conducted between 2008 and 2013

282 cant between-group difference in the odds of urinary incontinence was noted at 15 years.

283 After prostatectomy, urinary incontinence was observed, but urinary irritatio

284 Complete resolution of urgency urinary incontinence was reported by 13% and 27% of the

285 Self-reported urinary incontinence was worse at 1 year for those in th

286 heart failure, coronary artery disease, and urinary incontinence were associated with an increased r

287 All 38 men with no baseline urinary incontinence were leak-free and pad-free by 9 mo

288 , diagnosis, results, and treatment of mixed urinary incontinence were selected for review.

289 e-control study, urinary catheterization and urinary incontinence were the only factors associated wi

290 nce abuse, pain (spinal and peripheral), and urinary incontinence, whereas NOP antagonists have been

291 rial involving women with idiopathic urgency urinary incontinence who had five or more episodes of ur

292 ropubic urethropexies, and for managing urge urinary incontinence with anticholinergic medications.

293 level 1 evidence in the management of stress urinary incontinence with multicentric randomized contro

294 patient developed orthostatic hypotension or urinary incontinence with the requirement for urinary ca

295 high-quality (level 1) evidence for treating urinary incontinence with weight loss, for treating stre

296 0.11 [CI, 0.07 to 0.14]) but did not resolve urinary incontinence, with no significant dose-response

297 A review of the diagnosis of male urinary incontinence, with particular reference to studi

298 role of preoperative urodynamics for stress urinary incontinence, with particular reference to the c

299 Anticholinergic drugs resolved urinary incontinence, with similar effects from oxybutyn

300 77% of women residing in nursing homes have urinary incontinence, yet only 25% seek or receive treat